{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:13:01Z","timestamp":1781100781694,"version":"3.54.1"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jdcr.2024.01.028","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T21:09:23Z","timestamp":1707253763000},"page":"30-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ingenol mebutate\u2013associated immune thrombocytopenic purpura"],"prefix":"10.1016","volume":"46","author":[{"given":"Hafsa","family":"Zuberi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanober A.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.jdcr.2024.01.028_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113377","article-title":"Immunothrombotic mechanisms induced by ingenol mebutate lead to rapid necrosis and clearance of anogenital warts","volume":"23","author":"Braun","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jdcr.2024.01.028_bib2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jaad.2019.07.083","article-title":"Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm2 on the chest: a phase 3 randomized controlled trial","volume":"82","author":"Hanke","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2024.01.028_bib3","first-page":"40","article-title":"Ingenol mebutate gel (picato): a novel agent for the treatment of actinic keratoses","volume":"39","author":"Fidler","year":"2014","journal-title":"P T"},{"issue":"3","key":"10.1016\/j.jdcr.2024.01.028_bib4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2010.12.038","article-title":"Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response","volume":"66","author":"Rosen","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2024.01.028_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/12034754221143091","article-title":"Ingenol mebutate is associated with increased reporting odds for squamous cell carcinoma in actinic keratosis patients, a pharmacovigilance study of the FDA adverse event reporting system (FAERS)","volume":"27","author":"Jedlowski","year":"2023","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.jdcr.2024.01.028_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.36849\/JDD.5328","article-title":"Ingenol mebutate and the treatment of actinic keratosis","volume":"20","author":"Heron","year":"2021","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"10.1016\/j.jdcr.2024.01.028_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/14740338.2021.1915280","article-title":"Safety of topical interventions for the treatment of actinic keratosis","volume":"20","author":"Koch","year":"2021","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"10.1016\/j.jdcr.2024.01.028_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4103\/ijd.ijd_820_20","article-title":"A case of new-onset pemphigus erythematosus after topical application of ingenol mebutate","volume":"66","author":"Yang","year":"2021","journal-title":"Indian J Dermatol"},{"issue":"21","key":"10.1016\/j.jdcr.2024.01.028_bib9","article-title":"RF-herpes zoster triggered by ingenol mebutate gel: first European case report","volume":"S0001-7310","author":"Garayar Cantero","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed)"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:26:00Z","timestamp":1762475160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512624000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":9,"alternative-id":["S2352512624000420"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.01.028","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ingenol mebutate\u2013associated immune thrombocytopenic purpura","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}